PA
HBNC icon

PharVision Advisers’s Horizon Bancorp HBNC Stock Holding History

PharVision Advisers’s Portfolio HBNC Stock Details HBNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,610
Closed -$235K – 376
2024
Q4 		$235K Buy
+14,610
New +$245K 0.2% 242

Other funds holding HBNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
PCA
PL Capital Advisors Naples, Florida $332M AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
MCM
Maltese Capital Management New York $508M AUM 21.31% 1-Year Est. Return

PharVision Advisers's HBNC Position: Q1 2025 in Review

PharVision Advisers sold out of Horizon Bancorp (HBNC) in Q1 2025, closing a stake of 14,610 shares — an estimated $235K sold.

PharVision Advisers first reported a position in HBNC in Q4 2024 and held it in 1 quarter. The position peaked at $235K in Q4 2024. 184 funds tracked by Wall St. Rank hold HBNC as of Q1 2025.

  • PharVision Advisers reported no remaining Horizon Bancorp position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 14,610 Horizon Bancorp shares in Q1 2025, an estimated $235K.
  • PharVision Advisers first reported a position in Horizon Bancorp in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Horizon Bancorp position peaked at $235K in Q4 2024.
  • 184 funds tracked by Wall St. Rank held Horizon Bancorp as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.